Skip to main content
Clinical Trials/JPRN-UMIN000006995
JPRN-UMIN000006995
Completed
未知

Basic analysis of new evaluation method in neoadjuvant chemotherapy (Additional study of phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancer) - CTC in neoadjuvant chemotherapy trial (cTAC trial)

Surgery, Kyorin university hospital0 sites10 target enrollmentJanuary 1, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Colorectal cancer with unresectable liver mttastasis
Sponsor
Surgery, Kyorin university hospital
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This clinical trial was discontinued due to a lack of case accumulation.

Registry
who.int
Start Date
January 1, 2012
End Date
March 30, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Surgery, Kyorin university hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with known severe drug hypersensitivity or drug allergies 2\) Multiple primaries 3\) Metastasis except for liver and regional lymph nodes 4\)Infection (fever of 38 degrees C or over) 5\) Severe complications (interstitial pneumonia or pulmonary fibrosis, cardiac failure, renal failure, liver failure, uncontrollable diabetes or hypertension, jaundice) 6\) Pleural effusion or ascites requiring treatment 7\) Diarrhea (water like) 8\) During treatment of atazanavir sulfate or flucytosine 9\) Pregnant women and women suspected of being pregnant and lactating woman 10\) Doctor evaluate inappropriate 11\) Thrombosis in arteries or veins

Outcomes

Primary Outcomes

Not specified

Similar Trials